Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • An estimated 1.75 million Americans currently have age-related macular degeneration (AMD). That number is expected to grow to 2.95 million by 2020. * Note that an additional 7.3 million currently…  
  • An estimated 79,268 Americans ages 50-54 have age-related macular degeneration (AMD). That grows to 231,373 at ages 75-79 and more than 1.3 million for ages 80+.  
  • An estimated 2.4 million Americans over the age of 40 have low vision.  
  • Currently an estimated 38 million Americans suffer from blindness, low vision, or an age-related eye disease. That number is expected to grow to around 50 million by 2020.  
  • Between 40% and 45% of all diabetics have some stage of diabetic retinopathy.